G Medical Innovations Holdings Ltd.

G Medical Innovations Holdings Ltd. (GMVD) priced its initial public offering on Jun 28, 2021 at $5.00 per share, raising $15M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $67.3M. Benchmark was lead-left underwriter. Sullivan & Worcester and Carey Olsen advised the company and Ellenoff Grossman & Schole advised the underwriters.

G Medical Innovations Holdings Ltd. is an early commercial stage healthcare company developing mobile health and telemedicine devices, software and monitoring services, with a focus on cardiovascular disease, pulmonary disease and diabetes. It targets professional healthcare markets and consumers, mainly in the United States and China.

Status

IPO

Ticker

GMVD

Exchange

Nasdaq Capital Market

Priced

Jun 28, 2021

IPO price

$5.00

Raised

$15M

Market cap at IPO price

$67.3M

First filed

May 17, 2019

Underwriters

Benchmark

Company counsel

Sullivan & Worcester and Carey Olsen

Underwriters' counsel

Ellenoff Grossman & Schole

Sector

Healthcare

Country / state

Israel

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.